Diana Motei is a dedicated researcher in the field of life sciences, specializing in Type 2 Diabetes (T2D). Her PhD, focused on the discovery of biomarkers associated with insulin resistance and the progression towards T2D. Currently, is affiliated with the University of Roehampton, where she actively worked on clinical trials aimed at identifying key biomarkers that can aid in the early detection and management of insulin resistance and T2D.
Diana Motei is a dedicated researcher in the field of life sciences, specializing in Type 2 Diabetes (T2D). Her PhD, focused on the discovery of biomarkers associated with insulin resistance and the progression towards T2D. Currently, is affiliated with the University of Roehampton, where she actively worked on clinical trials aimed at identifying key biomarkers that can aid in the early detection and management of insulin resistance and T2D.